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Abstract 
We purified three homologous antimicrobial peptides (‘gallinacins’) from chicken leukocytes, examined their antimicrobial activity in vitro, and 
established their primary sequences by a combination of gas phase microsequencing and on-line IX-ESI-MS analysis of endo- and exoprotease peptide 
digests. The peptides contained 3&39 amino acid residues, were relatively cationic due to their numerous lysine and arginine residues, and each 
contained 3 intramolecular cystine disulfide bonds. Gallinacins showed primary sequence homology to the recently delineated p-defensin family, 
heretofore found only in the respiratory epithelial cells and neutrophils of cattle, suggesting that /3-defensins originated at least 250 million years ago, 
before avian and mammalian lineages diverged. The 9 invariant residues (6 cysteines, 2glycines and 1 proline) common to avian gallinacins and bovine 
p-defensins are likely to constitute the essential primary structural motif of this ancient family of host-defense peptides. 
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1. Introduction 
Mammalian phagocytes are equipped with an array of 
antimicrobial polypeptides which enhance their ability to 
kill ingested microbes [ 1,2]. Among these are several well 
characterized cysteine-rich cationic peptides, including 
defensins [3,4], /?-defensins [5] and protegrins [6]. Defen- 
sins have been isolated from polymorphonuclear leuko- 
cytes (PMN) of rabbits, humans, rats and guinea pigs; 
from the alveolar macrophages of rabbits, and from 
small-intestinal Paneth cells of mice and man (reviewed 
in [4]). B-defensins, originally isolated from bovine respi- 
ratory epithelial cells [7] and bovine PMNs [5], are 
slightly larger (38-40 aa residues) than classical defensins 
(29-35 residues), and are not formally homologous to 
them. Although both j& and classical defensins possess 
three intramolecular cystine disulfide bonds, neither the 
spacing of their cysteine residues nor the connectivity of 
their intramolecular cystine disulfide bonds [8,9] is iden- 
tical. 
Although little is known about the antimicrobial pep- 
tides of leukocytes from non-mammalian vertebrates, 
chicken PMN were shown to contain at least 3 cationic 
polypeptides that killed Escherichia co/i, Serratia marces- 
tens and Staphylococcus albus in vitro [ 10,111. Although 
these antimicrobial molecules were not precisely charac- 
terized, they were deemed arginine-rich by histochemical 
*Corresponding author. Fax: (1) (310) 206 8766. 
criteria (ammoniacal silver reactivity), and were reported 
to be stored in large (l-3 pm diameter), rod-shaped 
dense cytoplasmic granules [l l] whose contents dis- 
charged into phagosomal vacuoles that formed after 
chicken PMN ingested bacteria [lo]. This report de- 
scribes the purification and characterization of three cat- 
ionic, lysine and arginine-containing, cysteine-rich an- 
timicrobial peptides (‘gallinacins’) from the leukocytes of 
the domestic chicken, Gallus gallus. Remarkably, these 
peptides proved to be homologous to the recently de- 
scribed bovine j?-defensins. 
2. Materials and methods 
2.1. Chicken peritoneal neutrophils 
Sterile peritoneal exudates were harvested from 30 adult Cross 
Broiler-6 strain chickens 6-8 h after injecting 200 ml of saline with 0.5% 
starch. Approximately 4.5 x lo9 cells, (95% heterophils) were extracted 
with 40 ml of ice cold 10% HOAc, and the supematants were concen- 
trated by vacuum centrifugation. 
2.2. PuriJication of gallinacins 
The dried extract was dissolved in 5% HOAc and chromatographed 
on Acrilex P-10 (Reanal, Hungary). Gallinacins emerged slightly after 
one bed volume, and were purified on a 4.6 x 250 mm Vydac C-18 
RP-HPLC column using a linear gradient of acetonitrile with 0.1% 
TFA. The first peak (partially purified gallinacin-1) was rechromato- 
graphed using 0.13% HFBA for ion pairing. The second major peak (a 
mixture of Gal-la, Gal-2 and Gal-3) was purified by preparative con- 
tinuous acid urea gel electrophoresis (CAU-PAGE) -with a Bio-Rad 
Prep Cell 491 (Bio-Rad, Hercules, CA) as previously described [12], 
followed by reversed-phase HPLC. Gallinacin 3, which was N-termi- 
nally blocked, will not be described further in this report. 
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2.3. Antimicrobial testing 
Column fractions and tinal products were tested against Escherichia 
coli ML-35, Listeria monocytogenes strain EGD and Candida albicans 
strain 820, by an ultrasensitive radial diffusion technique [13]. The 
underlay agars contained pH 7.4 buffer (9 mM sodium phosphate, 1 
mM sodium citrate), 1% w/v agarose and 0.30 mg/ml of trypticase soy 
broth powder (BBL, Cockeysville, MD). 
2.4. Biochemical analysis 
Tricine-SDS-PAGE [ 141 and AU-PAGE [ 151 were performed in mini- 
gel formats (SE 250 unit, Hoefer Scientific, San Francisco, CA). Puri- 
fied gallinacins were hydrolysed in vacua in 5.7 N HCl for 36 to 40 h, 
derivatized with PITC and quantitated as phenylthiocarbamyl deriva- 
tives [16]. Half-cystine residues were quantified with performic acid- 
oxidized peptides and reduced and carboxymethylated (CM-) peptides 
after desalting by RP-HPLC. Approximately 400 pmol of each CM- 
gallinacin was microsequenced (ABI 475A sequencer). 
2.5. Endoprotease mapping of carboxymethylated (CM/ gallinacins 
Arg-C digestion of CM-Gal-l was performed at an enzyme/substrate 
mass ratio (E/S MR) of l/50 with 1 nmol of CM-Gal-l in 55 ~1 of 0.1 
M Tris, 10 mM CaCl,, 5 mM DTT and 0.5 mM EDTA, pH 7.6. Lys-C 
digestion (E/S MR 1130) was done with 1.5 mnol each of CM-Gal-l and 
CM-Gal-la in 22 ~1 of 25 mM Tris buffer (pH 8.5), 1 mM EDTA and 
0.5 M urea (pretreated with methylamine). After 16 h at 37°C the 
digestions were quenched by adding glacial HOAc, final 25% v/v. The 
digests were dried, dissolved in 0.1% TFA and purified by RP-HPLC. 
Amino acid composition of each fragment was determined, and selected 
fragments were sequenced. 
Trypsin digestion (E/S MR 1150) was performed with 2 nmol of 
CM-Gal-2 in 20~1 of 0.1 M NH,HCOJ, pH 8.15, for 4 h at 37°C. Amino 
acid composition of each purified tryptic fragment was determined and 
the C-terminal fragment was identified. Approximately 100 pmol of this 
fragment was subjected to sequence and mass analyses. 
2.6. Carboxyl-terminal sequencing 
The carboxyl-terminal mino acid of Gal-2 was determined by ana- 
lyzing residues released by carboxypeptidase-Y. Since our amounts of 
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purified Gal-l and la were limited, ‘on-line’ mass analysis was used to 
ascertain their carboxyl-terminal mino acid sequences. 
Approximately 200 pmol each of CM-Gal- 1 or la in 8 ~1 of 0.1 M 
NH,OAc, pH 6.2 was incubated at 37°C for 10 min. Carboxypeptidase- 
Y was added (E/S MR l/75), aliquots were removed after 3, 5 and 40 
min, and quenched with glacial HOAc (25% v/v final) and frozen for 
subsequent LC-MS analysis. CM-gal-2 (3 nmol) was digested with 
carboxypeptidase-Y as above, aliquots were removed at 1.5. 3, 5 and 
10 rnin and the released amino acid(s) were determined as phenylthio- 
carbamyl derivative(s). 
2.7. LC-Electrospray mass spectrometry 
Mass spectrometric analyses were performed on a triple quadrupole 
TSQ-700 mass spectrometer (Finnigan-MAT, San Jose, CA) equipped 
with an electrospray ion source operating at atmospheric pressure. 
Mass spectra were recorded in positive ion mode. The microcapillary 
HPLC system, constructed at the City of Hope (Duarte, CA), consisted 
of a fused silica column with an inner diameter of 250 pm packed with 
Vydac 3 pm Cl8 RP support. A detailed description of the design and 
operation was reported recently [17,18]. Mass scans were acquired 
every three seconds in a mass range from 500-2000 and the data collec- 
tion was monitored using both the base peak (representing the highest 
intensity per scan) and the reconstructed ion current profile (represent- 
ing the continuous collection of the total ion current per scan). Spectra 
were generated by averaging the scans containing the peak, and the 
mass assignments were made using the Finnigan MAT BIOMASS data 
reduction software. 
3. Results and discussion 
3.1. PuriJication of gallinacins 
Fig. 1A illustrates the initial RP-HPLC purification of 
the low molecular weight peptide mixture recovered after 
Acrilex PlO chromatography. Gallinacins emerged in 
two peaks between 3640% acetonitrile. Gallinacin- 1 
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Fig. 1. A: RP-HPLC purification of gallinacins. Pooled, concentrated P-10 fractions were chromatographed on a Vydac C-18 column using a linear, 
1% /min gradient of acetonitrile that contained 0.1% TFA. Peak 1 (mainly gallinacin-1) was repurified by RP-HPLC. Peak 2 (a mixture of 
gallinacins-la, -2, and -3) was subjected to CAU-PAGE purification, B: Further purification of gallinacin-1. Peak-l (Fig 1A) was rechromatographed 
with linear, 0.5% /min gradient of acetonitrile that contained 0.13% HFBA to yield pure gallinacin-1. AUFS signifies absorbance units full scale, 
and corresponds to 100% absorbance on the ordinate. Insert: AU-PAGE of purified gallinacins. Lane 1, - 10 pug of mixture of low molecular weight 
chicken peptides prior to RP-HPLC purification; Lanes 24 contain 1 pg each of purified gallinacin-lee, -1, and -2. The gel was stained with Coomassie 
blue that contained 15% formaldehyde. 
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Fig. 2. Amino acid sequences. The primary structures of gallinacins are shown, numbered according to gallinacin-la, and aligned with bovine tracheal 
antimicrobial peptide (TAP) and representitive bovine neutrophil peptides (BNBD). The 9 conserved residues are boxed. 
(peak 1) was purified with a slower acetonitrile gradient 3.2. Characterization of gallinacins 
that contained 0.13% HFBA (Fig. 1B). Gallinacins la Amino acid composition analysis indicated that 6 half- 
and -2 and -3 (peak 2) were resolved by sequential CAU- cystine residues were present and that gallinacin-la and 
PAGE and RP-HPLC. The purified gallinacins were ho- -1 were very similar (data not shown). Automated se- 
mogeneous by AU-PAGE (Fig. 1) and silver-stained quence analysis was carried out on - 400 pmols of each 
Tricine-SDS-PAGE (not shown). carboxymethylated peptide, supplemented and con- 
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Fig. 3. LC-ESI-MS analyses of CM-Gal-la digestion mixture Top: the Shaded inset shows the reconstructed ion current profile of 50 pmol of the 
3 min carboxypeptidase-Y digest. Peak 1 indicates undigested material, Peak 2 shows the first cleavage product. The mass spectra derived from peak 
1 (top) and peak 2 (bottom) are also shown. The corresponding deconvoluted masses are shown in the insets. 
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firmed by endoprotease and carboxypeptidase-Y diges- 
tions. All final data were unambiguous. The greatest 
challenges involved placement of the carboxyl-terminal 
residues. Identification of Ala and Asn in Gal-2 was 
accomplished conventionally by kinetic measurement of 
amino acid(s) released by carboxypeptidase-Y. The third 
residue, Trp, was placed by mass measurement of the 
C-terminal tryptic fragment. Since residues at positions 
32 (Trp) and 33 (Pro) had already been established by 
two independent sequence runs, the mass value of 673.3 
obtained for this fragment indicated that another Trp 
was the only possible fit at position 34. (Note, that posi- 
tion 34 of Gal-2 corresponds to residue 37 of Gal-la, 
which was used to establish the numbering scheme 
shown in Fig. 2). The presence of two tryptophan resi- 
dues in the Gal-2 sequence was further confirmed (data 
not shown) by spectrophotometric measurement [ 191. 
We placed the carboxyl-terminal tryptophan in 
gallinacin-lol and gallinacin-1 by ‘on-line’ LC-Electro- 
spray-Mass-Spectrometric analysis of carboxypeptidase- 
Y digestion mixtures. As indicated by the reconstructed 
ion current profile (Fig. 3, Shaded inset), several peaks 
were obtained when we subjected the 3 min carboxypep- 
tidase digestion mixture of CM-Gal-la to LC-MS. The 
corresponding mass spectra of the major peak (Peak 1) 
and the peak immediately preceeding it (Peak 2) are also 
shown in Fig. 3. The deconvoluted average masses for 
these two peaks (insets) were 4937.0 and 4751 .O, respec- 
tively. The first value corresponds to the undigested CM- 
Gal- la mass value. The second value, 186 mass units less 
than that of the undigested peptide, is consistent only 
with tryptophan being the carboxyl-terminal residue, 
which was also consistent with our spectrophotometric 
measurements (data not shown).. A similar mass differ- 
ence was observed with carboxypeptidase digestion stud- 
ies of CM-Gal-l. 
The calculated average mass values of native 
gallinacin-la, gallinacin-1 and gallinacin-2, if the 6 half- 
cystines are linked in three intramolecular disulfide 
bonds, are 4,581.51, 4,504.43 and 3,915.58. The respec- 
tive ESI-MS measurement yielded average mass values 
of 4,582.0, 4,505.O and 3,916.0, consistent with the ex- 
pected values. 
As shown in Fig. 2, Gal-la and Gal-l differed only in 
three positions, Asn”/Ser lo, Tyf’/Se?’ and His3’/Tyr3*. 
The additional positive charge resulting from the differ- 
ence at residue 32 is consistent with Gal-lol migrating 
slightly in advance of Gal-l in AU-PAGE gels, as noted 
in Fig. 3. Gal-2 (36 residues) was identical to Gal-l (39 
residues) in 15 of its 36 residues (41.7%), notwithstand- 
ing its 3 residue N-terminal truncation and 2 residue 
C-terminal elongation relative to Gal-l. Gal-2 also dif- 
fered from Gal-l and Gal-la by having only four resi- 
dues, instead of six, between its first and second cys- 
teines. The overall effect of these truncations was to 
delete three positively charged residues from the amino 
A8oC’ ____j---. ---_il _ _ 
I 
60 - 
40 - 1 
20 
E toll. 
g 80 
5 60 
40 
20 I L monocytogenes : 
o--- 
10 100 1000 
fi I I 
b 
60 
/ 
ok 1 rL--o----o -- I 
10 100 1000 
PEPTIDE CONCENTRATION (&ml) 
Fig. 4. Antimicrobial activity of purified gallinacins. Purified gallinac- 
ins, rabbit defensin NP-1 and human defensin HNP-I were tested 
against E. coli ML-35p, L. monocytogenes EGD and C albicans by 
radial diffusion assay. Stock concentrations of gallinacins and HNP-1 
were measured by absorbance at 280 nm and verified by amino acid 
analysis. NP-1 concentrations were determined by amino acid analysis 
only. 
terminus of Gal-2, perhaps accounting for its very poor 
activity, relative to Gal 1 and Gal la , against C. albicans 
(vide infra). 
When we aligned the gallinacin sequences with those 
of bovine tracheal antimicrobial peptide (‘TAP’ [7]) and 
several bovine neutrophil/3_defensins (BNBD, [5]) strik- 
ing homology was apparent, involving all six conserved 
cysteine residues as well as three other residues (Gly”, 
Pro” and Gly2’j) as shown in Fig. 2. The spacing of the 
gallinacin cysteine residues was virtually identical to that 
of /3-defensins, but it was quite distinct from that of 
classical defensins. 
3.3. Antimicrobial activity of gallinacins 
Gal-l and ICC were approximately as powerful against 
E. coli ML-35 as was the highly efficacious rabbit neutro- 
phi1 defensin NP-1, and they were both approximately 
1 O-fold more potent than human defensin HNP- 1. Al- 
though Gal-2 was slightly less effective, its activity also 
far exceeded that of HNP-1 (Fig. 4A). Gallinacins 1, la 
and 2 were highly and almost equally effective against L. 
monocytogenes, strain EGD (Fig. 4B). Although Gal-l 
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and lol killed C. albicans well, Gal-2 was ineffective even 
when applied at concentrations of 400 mg/ml (Fig. 4C) 
It is increasingly evident that mammals use various 
endogenous antimicrobial peptides for host defense, in- 
cluding cysteine-rich defensins [4], /3-defensins [5,7], pro- 
tegrins [6], bactenecin dodecapeptide [20], eNAPs 
[21,22], several proline and arginine-rich molecules 
[23,24], and cecropin-like peptides [25]. Although pep- 
tides analogous to mammalian defensins and protegrins 
have also been found in invertebrates, including insects 
(e.g. ‘insect defensins’ [26,27]) and horseshoe crabs (e.g. 
‘tachyplesins’ [28,29]) and similar cysteine-rich antimi- 
crobial peptides are also produced by many plants [30], 
surprisingly little is known of the evolutionary history 
and relatedness of these various peptide families. 
In their function and primary structure, chicken 
gallinacins closely resembled /?-defensins, recently de- 
scribed antibiotic peptides produced by the respiratory 
tract epithelial cells [7] and PMN [6] of cattle. Although 
bovine /3-defensins and classical defensins have different 
disulfide pairing patterns [8,9], the disulfide pairing of 
gallinacins remains to be established. 
All of the 9 invariant residues common to gallinacins 
and the 14 currently known bovine B-defensins, are im- 
portant determinants of molecular shape: the six cys- 
teines by forming intramolecular disulfide bonds and 
Gly”, Pro”, and Gly26 by participating in invariant turns 
[31]. The strict conservation of these nine residues im- 
plies that the ‘fold’ of gallinacins and /I-defensins will 
prove to be very similar. As the likely essential structural 
elements of the /I-defensin, these 9 residues merit desig- 
nation as the ‘&defensin core-motif. 
The finding of /I-defensin-like antimicrobial peptides 
in chicken indicates that j?-defensins are phylogenetically 
ancient effector molecules that arose before the avian 
and mammalian lines diverged, over 250 million years 
ago. Further insights into the evolutionary history of 
/3-defensins (and other components of the molecular ar- 
mamentarium inherited by man and other mammals) 
could result from performing analogous biochemical 
studies to those described here with leukocytes and other 
tissues from birds and other ‘lower’ vertebrates. 
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